Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Neuromodulation and neural interfaces

Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments.

Martin Jakobs; Anton Fomenko; Andres M Lozano; Karl L Kiening

Originally published in EMBO molecular medicine · 2019-04-01

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniques, such as stereotactic radiofrequency lesions. While serendipity has played a role in developing DBS as a therapy, research during the past two decades has shown that electrical neuromodulation is far more than a functional lesion that can be switched on and off. This understanding broadens the field to enable new types of stimulation, clinical indications, and research. This review highlights the complex effects of DBS from the single cell to the neuronal network. Specifically, we examine the electrical, cellular, molecular, and neurochemical mechanisms of DBS as applied to Parkinson's disease and other emerging applications.

Conclusion

Although the effects of DBS may often mimic a temporary lesion, the underlying mechanisms of action by far surpass simple inactivation of neurons. DBS has complex electrical effects on single neurons and neuronal networks, changes neurotransmitter concentrations and dynamics, and shapes the microenvironment including astrocytes, microglia, and endothelial cells. DBS also influences neuroplasticity and possibly induces neuroprotection and neurogenesis.

Editorial reading guide

  • How were patients or cases selected, and what did the authors use as a comparator?
  • Which outcomes, complications and follow-up intervals determine how far the findings apply?